BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+27.29%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.31B
AUM Growth
+$6.31B
(+17%)
Cap. Flow
-$8.53M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
41.19%
Holding
231
New
21
Increased
88
Reduced
44
Closed
16
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$74M |
| 2 |
Charles River Laboratories
CRL
|
$42M |
| 3 |
Abbott
ABT
|
$19.7M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$18.1M |
| 5 |
Arvinas
ARVN
|
$17.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$108M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$84.8M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$84.7M |
| 4 |
Gilead Sciences
GILD
|
$35.3M |
| 5 |
Teladoc Health
TDOC
|
$32.6M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Industrials | 0.45% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.09% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Regeneron Pharmaceuticals
REGN
$59.8B
| $8.26M | 0.13% |
+22,000
| New | +$8.26M |
|
102
Health Catalyst
HCAT
$228M
| $7.79M | 0.12% |
224,508
+64,292
| +40% | +$2.23M |
|
|
ONC
103
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $7.77M | 0.12% |
46,856
-25,244
| -35% | -$4.18M |
|
|
SILK
104
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $7.43M | 0.12% |
183,896
+51,942
| +39% | +$2.1M |
|
105
Phreesia
PHR
$1.81B
| $7.22M | 0.11% |
271,045
+50,355
| +23% | +$1.34M |
|
106
Veeva Systems
VEEV
$44.4B
| $7.16M | 0.11% |
50,884
| – | – |
|
|
VCRA
107
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.31M | 0.1% |
304,143
+54,970
| +22% | +$1.14M |
|
108
Kezar Life Sciences
KZR
$28.5M
| $6.22M | 0.1% |
155,067
+32,015
| +26% | +$1.28M |
|
109
Avantor
AVTR
$8.74B
| $5.71M | 0.09% |
314,566
+117,615
| +60% | +$2.13M |
|
110
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.68M | 0.09% |
+67,200
| New | +$5.68M |
|
111
Qiagen
QGEN
$10.1B
| $5.44M | 0.09% |
151,687
-450,872
| -75% | -$16.2M |
|
112
Zai Lab
ZLAB
$3.48B
| $5.02M | 0.08% |
120,782
+90,782
| +303% | +$3.78M |
|
|
SDC
113
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $4.63M | 0.07% |
530,230
+180,230
| +51% | +$1.58M |
|
|
LVGO
114
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $4.58M | 0.07% |
182,574
+139,354
| +322% | +$3.49M |
|
|
SGEN
115
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.27M | 0.07% |
37,400
-43,900
| -54% | -$5.02M |
|
116
AbbVie
ABBV
$374B
| $3.76M | 0.06% |
+42,500
| New | +$3.76M |
|
|
FIT
117
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $3.75M | 0.06% |
570,959
-2,088,985
| -79% | -$13.7M |
|
118
Alkermes
ALKS
$4.95B
| $3.44M | 0.05% |
+168,400
| New | +$3.44M |
|
|
QTNT
119
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $3.39M | 0.05% |
8,897
-9,800
| -52% | -$3.73M |
|
|
MNTA
120
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.2M | 0.05% |
162,400
+112,400
| +225% | +$2.22M |
|
121
Merck
MRK
$210B
| $2.73M | 0.04% |
+31,440
| New | +$2.73M |
|
|
SYNH
122
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.71M | 0.04% |
45,600
-16,400
| -26% | -$975K |
|
123
PTC Therapeutics
PTCT
$4.41B
| $2.69M | 0.04% |
56,100
-25,100
| -31% | -$1.21M |
|
124
Coherus Oncology, Inc. Common Stock
CHRS
$138M
| $2.67M | 0.04% |
148,500
-52,935
| -26% | -$953K |
|
125
Teva Pharmaceuticals
TEVA
$21.5B
| $2.61M | 0.04% |
266,000
+116,000
| +77% | +$1.14M |
|